These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Peptide deformylase inhibitors as antibacterial agents: identification of VRC3375, a proline-3-alkylsuccinyl hydroxamate derivative, by using an integrated combinatorial and medicinal chemistry approach. Chen D; Hackbarth C; Ni ZJ; Wu C; Wang W; Jain R; He Y; Bracken K; Weidmann B; Patel DV; Trias J; White RJ; Yuan Z Antimicrob Agents Chemother; 2004 Jan; 48(1):250-61. PubMed ID: 14693547 [TBL] [Abstract][Full Text] [Related]
3. Peptide deformylase inhibitors with non-peptide scaffold: synthesis and structure-activity relationships. Lee SK; Choi KH; Lee SJ; Lee JS; Park JY; Kim BM; Lee BJ Bioorg Med Chem Lett; 2011 Jan; 21(1):133-6. PubMed ID: 21146987 [TBL] [Abstract][Full Text] [Related]
4. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents. Calí P; Naerum L; Mukhija S; Hjelmencrantz A Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716 [TBL] [Abstract][Full Text] [Related]
5. Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor. Pratt LM; Beckett RP; Davies SJ; Launchbury SB; Miller A; Spavold ZM; Todd RS; Whittaker M Bioorg Med Chem Lett; 2001 Oct; 11(19):2585-8. PubMed ID: 11551755 [TBL] [Abstract][Full Text] [Related]
6. Structure--activity relationships of the peptide deformylase inhibitor BB-3497: modification of the P2' and P3' side chains. Davies SJ; Ayscough AP; Beckett RP; Clements JM; Doel S; Pratt LM; Spavold ZM; Thomas SW; Whittaker M Bioorg Med Chem Lett; 2003 Aug; 13(16):2715-8. PubMed ID: 12873500 [TBL] [Abstract][Full Text] [Related]
8. Heterocyclic methylsulfone hydroxamic acid LpxC inhibitors as Gram-negative antibacterial agents. McAllister LA; Montgomery JI; Abramite JA; Reilly U; Brown MF; Chen JM; Barham RA; Che Y; Chung SW; Menard CA; Mitton-Fry M; Mullins LM; Noe MC; O'Donnell JP; Oliver RM; Penzien JB; Plummer M; Price LM; Shanmugasundaram V; Tomaras AP; Uccello DP Bioorg Med Chem Lett; 2012 Nov; 22(22):6832-8. PubMed ID: 23046961 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the metal binding group. Smith HK; Beckett RP; Clements JM; Doel S; East SP; Launchbury SB; Pratt LM; Spavold ZM; Thomas W; Todd RS; Whittaker M Bioorg Med Chem Lett; 2002 Dec; 12(24):3595-9. PubMed ID: 12443784 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria. Yang S; Shi W; Xing D; Zhao Z; Lv F; Yang L; Yang Y; Hu W Eur J Med Chem; 2014 Oct; 86():133-52. PubMed ID: 25151577 [TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of macrocyclic peptidyl hydroxamates as peptide deformylase inhibitors. Shen G; Zhu J; Simpson AM; Pei D Bioorg Med Chem Lett; 2008 May; 18(10):3060-3. PubMed ID: 18093832 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of triazolyl-substituted benzyloxyacetohydroxamic acids as LpxC inhibitors. Hoff K; Mielniczuk S; Agoglitta O; Iorio MT; Caldara M; Bülbül EF; Melesina J; Sippl W; Holl R Bioorg Med Chem; 2020 Jul; 28(13):115529. PubMed ID: 32386952 [TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the methylene spacer and the P1' side chain. Davies SJ; Ayscough AP; Beckett RP; Bragg RA; Clements JM; Doel S; Grew C; Launchbury SB; Perkins GM; Pratt LM; Smith HK; Spavold ZM; Thomas SW; Todd RS; Whittaker M Bioorg Med Chem Lett; 2003 Aug; 13(16):2709-13. PubMed ID: 12873499 [TBL] [Abstract][Full Text] [Related]